Previous 10 | Next 10 |
home / stock / cslly / cslly news
My Project $1M portfolio, a high growth portfolio designed to outperform the S&P 500 has returned nearly 45% in 2020. Since inception, the portfolio has returned close to 25% annualized versus 14% for the S&P 500. MercadoLibre, Atlassian and Veeva were strong performers fo...
Pharming Group N.V. has filed to offer an estimated $10.9 million in Registered Holder shares in a U.S. offering. The firm is commercializing a treatment for hereditary angioedema and developing a treatment for pneumonia brought on by the Covid-19 virus. The firm is generating rev...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Prepare for a no-deal Brexit "There is now a strong possibility that we will have a solution that is more like an Australian relationship with the EU," Bor...
Sanofi (SNY) and GlaxoSmithKline (GSK), two of the world's biggest vaccine makers, have delayed advanced trials of their potential coronavirus vaccine after it produced an "insufficient" response in older adults.They now say their jab won't be ready until late next year and will commence a ne...
Seqirus Presents New Data at ESWI 2020 Demonstrating Safety and Immunogenicity of Adjuvanted, Cell-Based Pandemic Influenza A (H5N1) Vaccine SUMMIT, N.J. , Dec. 7 , 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and influenza pandemic response,...
Seqirus Presents New Late-Breaking Data at ESWI 2020 Highlighting Benefits of MF59®-Adjuvanted Seasonal Influenza Vaccine SUMMIT, N.J. , Dec. 7, 2020 /PRNewswire/ -- Seqirus, a global leader in influenza prevention and influenza pandemic response, today announc...
Project $1M, my 10-year, long-term investing program to attain $1M, had a strong November. While down against the S&P500 for the month, Project $1M still stands clear of the index year to date, at 42% vs 14.5% for the index. Mercadolibre, Visa, Mastercard and Nanosonics were l...
New Harris Poll Survey Finds Vast Majority of People Living with Hereditary Angioedema (HAE) Value Efficacy and Specific Correction of C1-INH Deficiency When Choosing an HAE Therapy PR Newswire KING OF PRUSSIA, Pa., Nov. 19, 2020 KING OF PRUSSIA, Pa. , Nov. 19,...
Urban League, CSL Behring Partner to Address Community Needs including Public Health, Workforce Diversity, Leadership Development 6 Urban League Affiliates across U.S. to participate -- starting with Philadelphia PR Newswire KING OF PRUSSIA, Pa. and PHILADELPHIA, Nov. 16...
CSL Behring To Present New Real-World Data on Outcomes Following Acute Coronary Syndrome at the American Heart Association (AHA) Virtual Scientific Sessions 2020 Global biotherapeutics leader reinforces commitment to cardiovascular research: Hosts Learning Studio with prominent ...
News, Short Squeeze, Breakout and More Instantly...
CSL Ltd ADR Company Name:
CSLLY Stock Symbol:
OTCMKTS Market:
CSL Behring Announces Positive Reimbursement Decision in Canada for HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B Canada NewsWire The positive decision from the Canadian Agency for Drugs and Technologies in Health (CADTH) recognizes the im...
CSL Seqirus Begins Shipping Its Portfolio of Influenza Vaccines for the 2024/25 Flu Season PR Newswire CSL Seqirus is the only manufacturer to offer a differentiated influenza vaccine for all eligible people aged six months and older in the United States . Centers for ...
CSL Seqirus, a Proud Champion of Pandemic Preparedness, Announces U.S. Government Award in Response to Avian Influenza PR Newswire CSL Seqirus to complete the fill and finish process for pre-pandemic vaccine to support the U.S. government's outbreak and preparedness response...